|
Published by: The Apex Group
Published: Oct. 1, 2000 - 55 Pages
Table of Contents
1. Introduction
2. The Context: Estimates for the Overall Diagnostics Market
Table 1. Worldwide In Vitro Diagnostics Sales Per Capita - 1996-2002
2.1 Diagnostic Testing
Table 2. Proportionate Market Share of the Main IVD Companies - 1998
Table 3. Worldwide In Vitro Diagnostics - Sales by Country - 1996-2002
Table 4. Global Medical Technology Market by Product Grouping - 1996
2.2 Infectious Disease as a proportion of the total
Table 5. Worldwide In Vitro Diagnostics - Sales by Product Type - 1996-2002
Table 6. Worldwide Nucleic Acid Assay Sales by Test Category - 1996-2002
Table 7. Rapid Microbiology Test and Instrument Market - W. Europe - 1990-2000
2.3 Main Market Trends
3. Diagnosing Tuberculosis in Humans
Figure 1. Reported TB Cases by World Region (% of Total) - 1997
3.1 Population
3.2 Estimated number of cases of TB
3.3 Regional variations
3.3.1 Developed World (Population 790 million)
3.3.2 Middle Developed World (Population 3 billion)
3.3.4 Under-developed World (Population over 2 billion)
Table 8. Existing Market for Diagnosis of TB and Potential Additional Market for the Diagnosis of TB (if all WHO estimated cases are tested)
4. Diagnosing Paratuberculosis in Cattle, Sheep and Goats
Table 9. Proportional breakdown of highest level of diagnosis by source
4.1 Explanation of Basis for Assumptions and Variables
4.1.1 Region
4.1.2 Proportion of species in affected operations
4.1.3 Proportion of cases in which diagnosis by testing is likely to be used
4.1.4 Cost of Tuberculin Testing per Animal
Table 10. Herd and Total Cattle Tests in Great Britain since 1995
Table 11. Costs Breakdown of Bovine TB Control Programme in Great Britain - 1996-97
4.1.5 Total cost of all animals likely to be properly 'tested'
4.1.6 Cost of testing all animals in affected operations
Table 12. Current and Potential Market estimates for testing of Sheep Cattle and Goats for Paratuberculosis 1998
5. Diagnosing M. bovis in Cattle
Figure 2. Bovine Tuberculosis Occurrence, Africa.
Figure 3. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Africa.
Figure 4. Bovine Tuberculosis Occurrence, Asia
Figure 5. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Asia
Figure 6. Bovine Tuberculosis Occurrence, Latin America and the Caribbean
Figure 7. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Latin America and the Caribbean
Table 13. Cattle Numbers - World - 1998
5.1 Estimated Value of Testing for Mycobacterium Bovis in Cattle
Table 14. Herd and Total Cattle Tests in Great Britain since 1995
5.1.1 Proportion of Animals Tested
5.1.2 Proportion of cases in which Laboratory Diagnosis is likely
5.1.3 Cost of testing
Table 15. Diagnosis of Bovine TB, 1998
6. Other TB Testing related markets
Figure 8. M. avium Subtypes
6.1 Avian Tuberculosis - Summary
6.2 HIV and Tuberculosis
Table 16. Estimated human tuberculosis and HIV-attributable tuberculosis cases in 1990, 1995 and 2000, by region
6.3 Extension of testing application
6.4 Summary of Diagnostic Techniques
6.4.1 RFLP
6.4.2 PCR
6.4.3 DNA Probes
6.4.4 Immunohistochemistry
6.4.5 Immunoblotting
6.4.6 Antigen-capture enzyme-linked immunosorbent assay
6.4.7 Antibody Detection
7. Conclusions
Table 17. Market Estimate - 1999
Table 18. Existing versus potential Market
8. Future prospects:
Table 19. Increasing incidence of TB
Table 20. Forecast estimates for the TB testing market 1998-2002
9. Glossary
10. Sources
10.1 Publications:
10.2 Organisations:
11. For More Information
AbstractThe World Health Organisation (WHO) describes TB as their biggest killer disease of humans globally. However the use of techniques used to identify the pathogen causing the illness are all subject to the "speed versus accuracy versus cost" ratio balance. In recent years there have been many advances in the use of biotechnology as a means of identifying clinical conditions. The development of this market will have a tremendous effect on the cost of tuberculosis identification necessary for better disease control. As a measure of the rate of development, the first section of this report will focus on the diagnostics market as a whole.
This reports sets out to identify the size and value of the rapid test kit market for Tuberculosis strains:
- M. tuberculosis
- M. avium ss paratuberculosis
- M. bovis
Get Full Details About This Report >>
|
